Prime Medicine PRME Operating Cash Flow
Operating Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Prime Medicine in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.
The official record: Prime Medicine’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Prime Medicine's operating cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Prime Medicine's operating cash flow?
- Prime Medicine (PRME) reported operating cash flow of -$42.71M in Q1 2026.
- How has Prime Medicine's operating cash flow changed year-over-year?
- Prime Medicine's operating cash flow increased by 12.6% year-over-year, from -$48.86M to -$42.71M.
- What is the long-term trend for Prime Medicine's operating cash flow?
- Over 2 years (2022 to 2025), Prime Medicine's operating cash flow has grown at a 11.0% compound annual growth rate (CAGR), from -$131.83M to -$162.56M.
- What does operating cash flow mean?
- Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.